A study found that the newer generation of much more effective diabetes medications are reaching only a fraction of the patients who are recommended to take them based on new guidelines.

With Novo Nordisk’s Wegovy already in the market, Eli Lilly is stepping up its game with a patient-friendly pen device, ...

CHICAGO -- A once-weekly basal insulin had similar safety and efficacy to a daily insulin option, a series of trials from the ...

In 2022, Gan & Lee also introduced a pre-filled insulin glargine pen in Pakistan, marking the first biosimilar of its type in the country. The newly approved cartridge further strengthens its ...

The first insulin biosimilar, Semglee (insulin glargine-yfgn), received approval in June 2020. 2 In July 2021, it also became the first biosimilar to receive an interchangeability designation from ...

During a phone interview with the “Al-Hayat” satellite channel, on Tuesday evening, Abdel-Ghaffar said that launching the first batch of locally manufactured insulin is an important step towards ...

Find patient medical information for Insulin Glargine on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings ...

Strengths: Tresiba and Lantus are both available in a strength of U-100. This means each drug comes in a form that contains 100 units of insulin per milliliter (mL) of solution.

TREVOSE, Pa., Nov. 7, 2022 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that it has entered into an agreement with Ypsomed AG, the manufacturer and supplier of the pen ...

Lannett previously said that subject dosing has been completed in the pivotal clinical trial of Lannett/HEC's biosimilar insulin glargine and no serious adverse events were reported. The company ...